Objective: to study the chemical therapeutic effects and efficacy enhancing and toxicity reducing of GAPSGF injection on mice who are treated with chemical therapeutic drug like Cytoxan.
One important feature of anthracycline+ taxane combinations is the higher risk of febrile neutropenia than is seen with single-agent therapy and with Adriamycin+ Cytoxan.
Experimental Study of Efficacy Enhancing and Toxicity Reducing Effect of Gapsgf Injection on Chemical Therapeutic Drug Cytoxan;
Docetaxel combined with Epirubicin and Cytoxan and 5-FU for locally advanced breast cancer neoadjuvant chemotherap